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Abstract The aim of this study was to establish cell
lines of adenocarcinomas of the gastro-esophageal junc-
tion(GEJ), which grow in vivo and in vitro. Primary
esophageal and gastric cardia adenocarcinomas and cor-
responding lymph node metastases were xenografted
subcutaneously to immunodeficient nude mice. In addi-
tion, tumor tissue was also used for in vitro culture.
Xenografting of 70 primary adenocarcinomas and 
17 metastases resulted in the initial growth of 22 and 
6 tumors, respectively (total 32%). Upon retransplanta-
tion, six long-term xenografts [esophageal adenocarci-
noma (OAC)P33X, OACP47X, OACP56X, OACP58X,
OACP67X, OACP76X] from primary tumors and three
(OACM2.1X, OACM30X, OACM53X) from metastases
were obtained. In vitro culture attempts of 34 primary 
tumors and nine metastases resulted in the establishment
of three (7%) permanent in vitro growing cell lines.
From one patient, a cell line from the primary tumor
(OACP4 C) and from a lymph node metastasis
(OACM4.1 C) was established. The third cell line
(OACM5.1 C) was also derived from a lymph node 
metastasis. The in vivo and in vitro cell lines were char-
acterized using immunocytochemistry and microsatellite
analysis to verify their epithelial and human tumor ori-
gin, respectively.
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Introduction
Despite the rising incidence of adenocarcinomas of the
gastro-esophageal junction (GEJ), little is known about
the cellular and molecular mechanisms underlying the
origin of these tumors. This is partly caused by the lack
of sufficient in vivo and in vitro model systems. Tumor
xenografts are useful models for studying the in vivo be-
havior of tumors. Furthermore, human tumor xenografts
are a source of tumor cells without an admixture of nor-
mal human cells. This facilitates the analysis of tumor
cell-specific molecular alterations, e.g., loss of heterozy-
gosity (LOH).
Until now, only a limited number of GEJ adenocarci-
noma xenografts have been reported in the literature [3,
10]. Also, only a few in vitro human GEJ adenocarcino-
ma cell lines have been established [1, 9]. In this study,
we report the generation of 28 xenografts and three cell
lines growing in vitro obtained from primary GEJ adeno-
carcinomas and lymph node metastases. From these xe-
nografts, nine permanent in vivo growing tumor lines
were obtained.
Materials and methods
Xenografting and in vitro culture
The surgical resection specimens were placed on ice shortly after
removal. Small tissue fragments were taken from the most vital
parts of the primary tumor and lymph node metastases and were
used for subcutaneous xenografting or tissue culture. Xenografting
was performed by subcutaneous implantation of two to six small
tumor fragments in female nude NMRI mice (6–8 weeks of age).
When growing tumors reached a size of about 5 mm in diameter
(between 2–4 months), the tumors were removed and small parts
were used for retransplantation.
For tissue culture, a piece of tissue from the primary tumor or
metastasis was rinsed in sterile Hanks balanced salt solution, sup-
plemented with penicillin and streptomycin, and cut into small
pieces with sterile scissors and forceps. The tissue fragments were
transferred to five to ten petri dishes, to which RPMI–1640 (Bio-
Whittakker, Verviers, Belgium) was added as culture fluid. This
was supplemented with 10% fetal calf serum and antibiotics. No
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growth factors or other additives were used. After 1 week of cul-
ture, the growth of cells could be observed along the edges of
some fragments. Initially, fibroblasts also started growing but, af-
ter a number of passages, they stopped growing, whereas the tu-
mor cells became adapted to the growth medium and started to di-
vide more rapidly. Cultures were passaged by trypsinization and,
after a number of passages, in vitro the cell lines were used for
transplantation to nude mice to verify their tumorigenic nature.
Cultured cells were trysinized and, after washing with tissue cul-
ture medium and phosphate buffered saline (PBS), suspended in
PBS in a concentration of 50×106 cells/ml. From this suspension
5×106 cells (0.1 ml) were injected subcutaneously into a nude
mouse.
Histology and immunocytochemistry
Primary tumors, metastases, and xenografts were routinely fixed
in 10% buffered formalin and embedded in paraffin. Sections 
(5-µm thick) were routinely stained with hematoxylin and eosin.
The presence of sialomucin was investigated using alcian blue
staining at pH 2 by routine procedure. Cells were also cultured on
glass slides, washed with PBS, and fixed in cold acetone for im-
munocytochemical detection of the epithelial marker, keratin. To
visualize the presence of specific antigens, the peroxidase–antiper-
oxidase (PAP) staining method was followed.
After preincubation with 10% normal rabbit serum, the slides
were incubated overnight with a specific monoclonal antibody
cocktail (clone AE1 and AE3 from Biogenex, Ramon, Calif.) at a
200× dilution. This antibody cocktail detects high molecular
weight (basic) and low molecular weight (acidic) cytokeratins. Af-
ter rinsing with PBS, the slides were incubated with a rabbit anti-
mouse immunoglobulin serum (Dako, Glostrup, Denmark) at a
25× dilution. Subsequently, a mouse antiperoxidase monoclonal,
to which peroxidase was coupled, was added (Sigma, Montesanto,
St. Louis, Mo.) at a 200× dilution. The cells were stained with di-
aminobenzoic acid (DAB), to which H2O2 was added and sealed.
As a positive control for cytokeratin staining, the colon carcinoma
cell line HT-29 was used.
DNA isolation, microsatellite analysis, and chromosome number
Polymorphic microsatellite marker analysis was used to verify the
derivation of the xenografts and cell lines and to confirm their tu-
mor cell nature by loss of heterozygosity. DNA was isolated from
cultured cells, frozen xenografts, and frozen patient normal and tu-
mor tissue by means of standard proteinase K digestion and phe-
nol/chloroform extraction.
Eight highly polymorphic microsatellite markers on chromo-
somes 14 and 16 were amplified using the polymerase chain reac-
tion (PCR), as described by Trapman et al. [13]. Markers D14S67,
D14S78, D14S1010, D14S1037, D16S265, D16S398, D16S503,
and D16S512 were amplified in a 15-µl reaction volume (contain-
ing 1.5 mM MgCl2, 0.02 mM dATP, 0.2 mM dGTP, 0.2 mM dTTP,
and 0.2 mM dCTP, 0.8 µCi α-32P-dATP, 20 pmol of each primer,
and 0.2 U Taq polymerase, Promega). PCR was carried out under
standard conditions. PCR products were size separated using elec-
trophoresis in a 6% polyacrylamide gel. After drying, the gels
were exposed overnight to X-ray film.
The chromosome number of the in vitro growing cell lines was
determined using a standard procedure. In short, the cell cultures
were treated overnight with colcemid, and the harvested cell sus-
pensions underwent a hypotonic shock in KCl. The cells were then
fixed in methanol/acetic acid, and the metaphase spreads were
stained with DAPI (4'-6'-diamidino-2-phenylindole). Chromosome




Based on the macroscopic and microscopic examination
of the resection specimens, the tumors around the GEJ
were classified as Barrett-related (n=16) or non-Barrett
adenocarcinomas, both from gastric and esophageal ori-
gin. The presence or absence of Barrett’s transformed
mucosa adjacent to the tumors discriminated Barrett’s
from non-Barrett’s adenocarcinomas, respectively. Of 16
Barrett’s adenocarcinomas seven were classified as poor-
ly differentiated, seven were moderately differentiated,
and two were well-differentiated. Of the 54 non-Barrett
adenocarcinomas 22 were undifferentiated, 30 were
moderately differentiated, and two were well-differenti-
ated (Table 1).
Xenografting
Primary adenocarcinomas of the GEJ (70 adenocarcino-
mas) and 17 lymph node metastases were xenografted to
nude mice. This resulted in the initial growth of 3 tumors
from 16 xenografts from Barrett adenocarcinomas and
19 tumors from 54 transplantations of non-Barrett
adenocarcinomas. After transplantation of the 17 lymph
node metastases (2 originating from Barrett tumors and
15 from non-Barrett carcinomas), six xenografts were
obtained, all originating from gastric cardia carcinomas.
Therefore, the total success rate of growing xenografts
was 32%. Repeated transplantations of xenografts result-
ed in the establishment of six long-term xenografts from
primary tumors and three from metastases. One of these
in vivo lines originated from a primary Barrett’s adeno-
carcinoma. The lines were given the notation OAC
(esophageal adenocarcinoma) of the primary tumor or of
the metastasis, respectively, followed by the tumor num-
ber and the xenograft. The following lines were obtained
from primary adenocarcinomas OACP33X, OACP47X,
OACP56X, OACP58X, OACP67X, and OACP76X 
and from metastases OACM2.1X, OACM30X, and
OACM53X.
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Table 1 Xenografting adenocarcinomas of the gastro-esophageal junction. Xenograft take was compared with histological grade of the
primary tumors or metastases. The data are expressed as the number of xenografts/number of primary tumors or metastases
Type Undifferentiated Moderately differentiated Well-differentiated Total take
Barrett n=16 1/7 2/7 0/2 3 (18.7%)
Non-Barrett n=54 7/22 10/30 2/2 19 (35.3%)
Metastases n=17 2/9 4/8 0/0 6 (35.2%)
There was no strict correlation between the degree of
differentiation and successful xenografting. Of the nine
lines, seven and two originated from moderately differ-
entiated and poorly differentiated tumors, respectively.
The three cell lines established from metastases were de-
rived from moderately differentiated tumors.
In vitro culture
Of the 70 primary GEJ adenocarcinomas and the 17 me-
tastases, 34 and 9, respectively, were also cultured in vit-
ro. Many of them became infected, and a number were
overgrown by fibroblasts. Ultimately three long-term in
vitro growing cell lines were established (7%).
Two cell lines, i.e., OACP4 C and OACM4.1 C, de-
rived from the same patient grew adherent in monolayer
and were pleiomorphic, with epithelioid and fibroblast-
oid cells with cytoplasmic protrusions (Fig. 1A). In the
cultures, several multinucleated giant cells (Fig. 1B)
were observed.
The third cell line, OACM5.1 C, was derived from a
lymph node metastasis from a patient suffering from a
Barrett’s adenocarcinoma. This cell line grew loosely at-
tached to the culture flask and in multicellular floating
spheroids. The cells were round or had a fibroblastoid
morphology (Fig. 1C). These three in vitro cell lines ap-
peared to be tumorigenic in nude mice and developed
subcutaneous tumors within 6–8 weeks.
Histology and immunocytochemistry
The histology of all xenografts, including those formed
by transplantation of cells from the three in vitro cell
lines, completely resembled the histology of the primary
tumor and metastatic derivatives resected from the pa-
tients. Figure 2A, B shows a primary differentiated tu-
mor and the corresponding xenograft, and Fig. 2C, D
shows the comparison of an undifferentiated primary tu-
mor with the xenograft from the in vitro cell line. With
the alcian blue staining, all xenografts appeared to har-
bor sialomucin-producing cells, as did the primary tu-
mors. The established xenografts and in vitro cell lines
were derived from invasive tumors. However, no inva-
sion into the surrounding tissue of the subcutaneous xe-
nografts was observed. All xenografts presented as en-
capsulated subcutaneous tumors. Variable cytoplasmic
expression of cytokeratin was demonstrated in all three
in vitro cell lines, confirming their epithelial nature (not
shown).
Microsatellite analysis and chromosome number
To confirm the derivation of the xenografts and in vitro
cell lines, their DNA was compared with the patient’s
tumor and normal DNA. With eight highly polymorphic
microsatellite markers, all alleles in the xenografts and
in vitro cell lines were present in the corresponding pri-
mary tumors and normal tissues (Fig. 3A, B). In addi-
tion, LOH was found with at least one of these markers
in the xenografts and three cell lines. The LOH patterns
were in all cases comparable with the LOH patterns
found in the matched primary tumors or metastases
(Fig. 3A, B).
All three in vitro cell lines appeared to be aneuploid.
OACP4 C and OACM4.1 C had 53–57 and 52–65 chro-
mosomes, respectively. OACM5.1 C was hypodiploid
with 39–41 chromosomes. Further karyotypic character-
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Fig. 1 Phase-contrast images of OACP4 C (A). Note the pleiom-
orphic nature and the multinucleate giant cells (B). OACM5.1 C
formed multicellular spheroids (C)
ization will be published as part of a separate report
(Rosenberg et al., unpublished observations).
Discussion
In general, the success rate of xenografts from GEJ
adenocarcinomas on nude mice is very reasonable, al-
though long-term establishment of these xenografts was
limited compared with that of other tumors [4]. The tu-
mor growth does not correlate with the tumor grade of
the tissue transplanted. Most lines were derived from
moderately and not from poorly differentiated tumors. It
is likely that the subcutaneous microenvironment or im-
paired vascularization may explain the many negative
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Fig. 2 Histology of differentiated xenograft OACP58X (A) com-
pared with that of the primary tumor (B). Comparison of the un-
differentiated xenograft of the in vitro cell line OACM4.1 C (C)
with the corresponding primary tumor (D)
A
B
P4 M4.1 T N
M53 T N
Fig. 3 A Microsatellite analysis with polymorphic marker
D14S1010 on in vitro primary tumor cell line OACP4 C (P4) and
metastasis cell line OACM4.1 C (M4.1). The primary tumor (T)
and normal DNA (N) were from the same patient. The patient was
heterozygous for this marker, and a complete loss of the upper al-
lele (arrowhead) was observed in the cell lines. A partial loss was
observed in the primary tumor. The upper allele in the primary tu-
mor was most likely derived from normal human cells present in
the tumor specimen. B Microsatellite analysis with polymorphic
marker D14S1010 on metastasis xenograft (M53X, first passage),
primary tumor (T), and normal DNA (N) from the same patient.
The patient is heterozygous for this marker. A complete loss was
observed in the xenograft, and a partial loss was observed in the
primary tumor (arrowhead)
cases. Alternatively, the sensitivity of tumor cells to the
natural killer cells of nude mice may hamper their out-
growth. Orthotopic transplantation of the established cell
lines to the cardia did not improve the outgrowth (un-
published results) despite the malignant nature [12] and
the genetic instability of these tumors [7]. The 87 prima-
ry transplantations resulted in the initial growth of 28 xe-
nografts (32%). After repeated retransplantations, only
nine (10%) xenografts could be established as permanent
lines. There was no correlation with pathological criteria
and long-term xenograft growth. LOH analyses revealed
that already in the first passage xenografts, obtained
2–4 months after primary transplantation, no contaminat-
ing normal human cells were present in the tumors
(Fig. 3B).
The xenografts were not contaminated with normal
human stromal cells. Therefore, they are of value for
comparative genomic hybridization [2, 13]. DNA from
xenografts was also used for mapping of deletions on the
long arm of chromosome 4 [10] and in studying E-cad-
herin and β-catenin mutations in GEJ adenocarcinomas
[15, 17]. The number of well-described permanent in vit-
ro GEJ adenocarcinoma cell lines is limited. Altorki et
al. [1] have reported the growth of three permanent cell
lines (SK-GT-1, 4, and 5) from which one was derived
from a Barrett’s carcinoma. Rockett et al. [9] generated 
a series of tumor cell lines called JROECL 19, 33, 47,
and 50. The cell line JROECL 33 originated also from a
Barrett’s adenocarcinoma. However, two lines, JROECL
47 and 50, proved to be subclones of the colon carcino-
ma cell line HCT 116 [16].
Palanca-Wessels et al. [8] established four permanent
cell lines from Barrett’s metaplastic epithelium, all of
which already showed polyploidy, LOH of chromosome
9p and, in three of four cultures, loss of 17p and p53 mu-
tations. More recently, a number of less well-character-
ized lines Seg-1, Flo-1, and Bic-1 were preliminarily re-
ported in a study on the differential expression of heat-
shock proteins in Barrett’s metaplasia and esophageal
adenocarcinomas [11].
Our in vitro cell lines expressed cytokeratin, indicat-
ing their epithelial nature. All xenografts, also from the
in vitro cell lines and from undifferentiated tumors, har-
bored sialomucin-containing cells, demonstrating their
derivation from adenocarcinomas. It is obvious that the
histology of the xenografts corresponded to that of the
primary tumor. Also, when the cells of the permanent in
vitro cell lines were transplanted to nude mice, they
gave rise to tumors, which were histologically similar
to the tumors from which they originated. However, all
primary tumors were invasive, whereas none of the sub-
cutaneous xenografts showed invasiveness. This is
comparable with, for example, colorectal tumor cell
lines which show no invasion after heterotopic trans-
plantation but invasion is observed at the orthotopic site
[14].
The microsatellite analysis of the primary tumor and
the corresponding xenograft or cell line proves their
common origin. All three in vitro cell lines were aneu-
ploid, in agreement with reports that most GEJ have ab-
errant ploidy levels [5]. The chromosome numbers of
cell lines OACP4 C and OACM4.1 C were in the same
range, and this is consistent with numerous reports on
comparable ploidy of paired primary tumors and metas-
tases. Cell line OACM5.1 C had a hypodiploid karyo-
type. Although uncommon, hypodiploidy has been de-
scribed in GEJ adenocarcinoma [6].
In conclusion, the results showed that GEJ adenocar-
cinoma cell lines growing in vivo and in vitro can be
successfully established and histologically, immunocyto-
chemically, and genetically resemble the tumors from
which they originated. These xenografts and cell lines
are a valuable source of homogeneous tumor tissue for
further investigations.
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